Quoin Pharmaceuticals Ltd ADR (QNRX) concluded trading on Wednesday at a closing price of $0.56, with 5.82 million shares of worth about $3.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.84% during that period and on December 18, 2024 the price saw a loss of about -6.65%. Currently the company’s common shares owned by public are about 5.05M shares, out of which, 1.12M shares are available for trading.
Stock saw a price change of -26.95% in past 5 days and over the past one month there was a price change of -6.25%. Year-to-date (YTD), QNRX shares are showing a performance of -88.53% which decreased to -86.15% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.48 but also hit the highest price of $6.18 during that period. The average intraday trading volume for Quoin Pharmaceuticals Ltd ADR shares is 2.93 million. The stock is currently trading -16.74% below its 20-day simple moving average (SMA20), while that difference is down -18.15% for SMA50 and it goes to -18.79% lower than SMA200.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) currently have 5.05M outstanding shares and institutions hold larger chunk of about 3.27% of that.
The stock has a current market capitalization of $2.84M and its 3Y-monthly beta is at 1.80. It has posted earnings per share of -$4.08 in the same period. It has Quick Ratio of 3.02 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for QNRX, volatility over the week remained 10.17% while standing at 17.76% over the month.
Stock’s fiscal year EPS is expected to rise by 78.42% while it is estimated to increase by 29.01% in next year.
